**Core Concept**
Leukoerythroblastosis is a condition characterized by the presence of immature white blood cells (leukocytes) and red blood cells (erythrocytes) in the peripheral blood. This phenomenon is often associated with bone marrow disorders, particularly those involving the myeloproliferative neoplasms.

**Why the Correct Answer is Right**
The presence of leukoerythroblastosis in this patient is suggestive of a myeloproliferative neoplasm, specifically Chronic Myeloid Leukemia (CML). CML is a type of cancer that affects the white blood cells and tends to progress slowly over time. The histopathologic findings, such as marked splenomegaly and moderate hepatomegaly, are consistent with CML. The leukoerythroblastosis is likely due to the overproduction of immature white blood cells in the bone marrow, which can lead to their presence in the peripheral blood. The BCR-ABL1 fusion gene, resulting from a translocation between chromosomes 9 and 22 (Philadelphia chromosome), is a hallmark of CML.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because it does not account for the presence of leukoerythroblastosis or the marked splenomegaly and hepatomegaly. While it is a type of anemia, it does not explain the specific findings in this patient.
**Option B:** This option is incorrect because it is not associated with leukoerythroblastosis or the specific histopathologic findings in this patient. Sickle cell anemia is a genetic disorder that affects hemoglobin production, but it does not typically cause leukoerythroblastosis.
**Option C:** This option is incorrect because it does not explain the presence of leukoerythroblastosis or the marked splenomegaly and hepatomegaly. While it is a type of bone marrow disorder, it is not typically associated with these specific findings.

**Clinical Pearl / High-Yield Fact**
It's essential to remember that leukoerythroblastosis is a non-specific finding that can be seen in various myeloproliferative neoplasms, including CML. The presence of this finding, combined with marked splenomegaly and hepatomegaly, should prompt further investigation into myeloproliferative neoplasms.

**Correct Answer:** C. Chronic Myeloid Leukemia (CML)